The primary objective of the study is to evaluate the efficacy of administered maintenance treatments in bipolar disorder I and II, defined as the percentage of patients who experience a relapse episode during the first 9 months after a mood event (manic or depressive).
Study Type
OBSERVATIONAL
Enrollment
294
Research Site
Aigio, Achaias, Greece
The proportion of patients (n, %) who will experience a relapse episode (manic, hypomanic, depressive, mixed)
Time frame: During the first 9 months after the acute mood episode or in case of relapse occurrence.
Description of administered treatments for the management of the acute phase of bipolar disorder [mood stabilizers (n,%), antidepressants (n,%), and antipsychotics (n,%)].
Time frame: 4 months and 9 months after the acute mood episode or in case of relapse occurrence
Description of management of relapse episodes in patients previously receiving treatment during the maintenance phase
Time frame: In all visits - during the whole study period (9 months)
YMRS total score, HAM-D total score
Time frame: At baseline and final visit (9 months after the acute mood episode)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Ag. Paraskevi, Attikis, Greece
Research Site
Athens, Attikis, Greece
Research Site
Chaïdári, Attikis, Greece
Research Site
Drapetsona, Attikis, Greece
Research Site
Elefsina, Attikis, Greece
Research Site
Glyfada, Attikis, Greece
Research Site
Ilissia, Attikis, Greece
Research Site
Kifissia, Attikis, Greece
Research Site
Koropí, Attikis, Greece
...and 23 more locations